IQE: a Tale of Two Jvs This Research Report Was Completed and First Distributed at 5Pm GMT on Friday 8 December 2017 Author: Matthew Earl - Managing Partner

Total Page:16

File Type:pdf, Size:1020Kb

IQE: a Tale of Two Jvs This Research Report Was Completed and First Distributed at 5Pm GMT on Friday 8 December 2017 Author: Matthew Earl - Managing Partner IQE: A tale of two JVs This research report was completed and first distributed at 5pm GMT on Friday 8 December 2017 Author: Matthew Earl - Managing Partner ShadowFall Capital & Research LLP Research Recommendation Disclaimer and Disclosures: Please note this final research report was completed and first distributed at 5pm GMT on Friday 8 December 2017. All information was up to date as of this date. Contact: [email protected] Author: Matthew Earl - Managing Partner ShadowFall Capital & Research LLP is authorised and regulated by the Financial Conduct Authority. This research report, which contains an implicit research recommendation, has been produced by ShadowFall Capital & Research LLP (“ShadowFall”), which is authorised and regulated by the Financial Conduct Authority in the United Kingdom (firm reference number 782080). This research report has been produced exclusively by Matthew Earl who is the managing partner of ShadowFall (the “author”). The report is for your sole use and provided to you subject to legal terms which must be adhered to at all times. This final research report was completed and distributed at 5pm GMT on Friday 8 December 2017. ShadowFall has taken all reasonable steps to ensure that factual information in this research report is true and accurate. However, where such factual information is derived from publicly available sources ShadowFall has relied on the accuracy of those sources. All statements of opinion contained in the research report are based on ShadowFall’s own assessment based on information available to it. That information may not be complete or exhaustive. No representation is made or warranty given as to the accuracy, completeness, achievability or reasonableness of such statements of opinion. This report is intended for FCA defined professional clients, who are expected to make their own judgment as to any reliance that they place on the research report. It is not suitable for, nor intended for any persons deemed to be a “Retail Customer” under the FCA Rules. In addition, distribution is not intended for any jurisdiction outside of which ShadowFall has permissions to distribute research. ShadowFall does not take responsibility or accept any liability for any action taken or not taken by the recipient of a research report as a result of information and/or opinions contained in a research report. Recipients must exercise their own judgment and where appropriate take their own investment, tax and legal advice prior to taking or not taking action in reliance on the contents of a research report. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations. Neither the authors nor ShadowFall is aware of any factor, subject to the paragraph below, which might reasonably be expected to impair their objectivity in the preparation of this updated research report. The authors and ShadowFall are not aware of any direct or indirect conflicts of interest, subject to the paragraph below, that might exist between the authors or ShadowFall and any issuer which is the subject of this research report (the “issuers”). In particular, neither the author nor ShadowFall has any affiliation with the issuers. ShadowFall manages an alternative investment fund (the “fund”) which inter alia takes positions in traded securities. At the time of distribution of this research report the fund holds no positions in the issuers, nor any options, swaps or other derivatives relating to the issuers. The fund may take positions in the issuers (long or short) at a future date once recipients of this research report have been given a reasonable opportunity to act after the date of receipt of this research report. ShadowFall is committed to providing services and products which are unbiased and impartial and have implemented a Conflicts of Interest Policy pursuant to FCA rules. The existence and content of this research report has not been discussed in any way with the issuers or their corporate brokers prior to completion and publication. Neither the authors nor ShadowFall has received any payment from the issuer, its corporate broker or any connected party for preparing this research report. Prior to completion and distribution, this research report has been seen by ShadowFall’s legal advisers and its regulatory advisers. For US recipients: This report is being distributed in the US in compliance with the “Foreign Private Adviser” exemption under rule 202(a)(30) of the Investment Advisors Act 1940. The information contained in this report is intended solely for institutional investors only and may not be used or relied upon by any other person for any purpose. Such information is provided for informational purposes only and does not constitute a solicitation to buy or an offer to sell any securities under any U.S. federal or state securities laws, rules or regulations. For Hong Kong recipients: This report is intended for Professional Investors only under the rules of the Hong Kong Securities and Futures Commission. ShadowFall Capital & Research LLP. All rights reserved. This document may not be reproduced or redistributed in whole or in part without prior written permission from ShadowFall Capital & Research LLP. 2 IQE: A tale of two JVs IQE is an AIM listed company, capitalised at £1.3 billion. It describes itself as the global leader in the design and manufacture of advanced semiconductor wafer products, with its products being used to produce the high performance components that enable a wide range of high-tech applications. Since 2009, IQE has: • Reported a cumulative £180.0 million in EBITDA. • Generated a cumulative £12.7 million in Free Cash Flow1. • Paid no dividends. • Spent a cumulative £59 million on acquisitions. • Raised around £166 million in capital; c. £147 million in equity issuance and c. £19 million in net debt issuance. Most recently a gross £95 million equity raise on 10 November 2017. • Prior to its recent equity raise, seen its net debt steadily rise. The headline performance of IQE portrays a company whose valuation we struggle to understand. We conclude that the market is pricing in stellar growth on the horizon. However, as the saying goes: “study the past if you would define the future”, and when we dig deeper into IQE’s recent past, we discover a range of accounting features, which increase our incredulity further. More specifically, our concern centres on the Group’s two JVs and a series of related party transactions, that appear to us to be somewhat circular. 1 The company’s reported Free Cash Flow stated in its annual filings from 2009 to 2016 is a cumulative total of £17.8 million. We estimate that in H1 2017 the group achieved a £5.1 million Free Cash Outflow. IQE defines its reported Free Cash Flow as net cash flow before acquisitions, financing and net interest paid. Our estimate for H1 2017 is derived using IQE’s definition. In H1 2017 the group reported £11.195 million cash inflow from operations, (£0.946 million) cash outflow on tax, (£9.604 million) cash outflow on investment in intangible fixed assets, and a (£5.763 million) cash outflow on purchase of PPE. Hence, H1 2017 reported Free Cash Outflow equals (£5.1 million) and therefore, cumulative Free Cash Flow since 2009 is estimated to be £12.7 million. ShadowFall Capital & Research LLP. All rights reserved. This document may not be reproduced or redistributed in whole or in part without prior written permission from ShadowFall Capital & Research LLP. 3 Summary of Findings • In 2014, IQE incorporated two companies that subsequently became JVs. • These JVs made significant contributions to IQE’s profitability in 2015 and 2016. The JVs contributed: • £8.0 million or 42% to 2015 adjusted EBIT. • £6.7 million or 30% to 2016 adjusted EBIT. • On an EV/EBIT basis, IQE trades on c. 60 times its 2016 EBIT. Sixty times the JVs’ 2016 profit would suggest that the market is attaching over £400 million in value relating to the profit generated by these JVs. • While IQE has reported significant profits from these JVs, by contrast the JVs have reported significant and growing losses. The JVs reported combined losses of: • c. £1.9 million in 2015; rising to • c. £6.3 million in 2016. • IQE has reported a cumulative £180.0 million in EBITDA since 2009. • IQE has reported a cumulative £12.7 million in Free Cash Flow since 20092. • We estimate that the JVs contributed: • £7.7 million towards (or 74% of) IQE’s Free Cash Flow in 2015; and • £7.0 million towards IQE’s Free Cash Flow in 2016. • Without the JVs’ cash contribution in 2016, we estimate that IQE would have reported negative FCF in 2016. Whereas the JVs purchase from IQE, and IQE purchases from the JVs, aside from IQE, it is not altogether clear that these JVs have any other customers. It is a somewhat circular state of affairs. On the basis of: • The joint control of these JVs; • The apparent lack of any other customers for these JVs, other than IQE; • The seemingly one way benefit to IQE from this relationship, where IQE books the profits and the JVs retain the losses; and • The cash flows from the JVs to IQE, that appear to have markedly improved IQE’s FCF. We have serious concerns about IQE’s governance, its reported profitability and sources of cash. 2 IQE’s reported Free Cash Flow from 2009 to 2016 is a cumulative total of £17.8 million. In line with IQE’s own definition of reported Free Cash Flow, we estimate that in H1 2017 the group achieved a c.
Recommended publications
  • Including Hospitality Given
    WELSH GOVERNMENT – ANDREW GOODALL, DIRECTOR GENERAL, HEALTH AND SOCIAL SERVICES Business Expenses: October 2015 – December 2015 OTHER Total DATES DESTINATION PURPOSE TRAVEL (Including Cost Hospitality Given) Accommodation Air Rail Taxi / Car / Meals 05/10/15 Cardiff Bay Meeting with all Chief Parking - £4.00 Executives from NHS £4.00 Wales 06/10/15 Cardiff Bay Meeting with First Minister Mileage - £10.90 and Minister for Health and £0.90 Social Services Parking - £10.00 06/10/15 St Asaph - Meetings with members of Mileage - Accommodation £221.30 North Wales Executive Team at Betsi £172.80 - £48.50 Cadwaladr University Health Board. 08/10/15 Cardiff Bay Meeting with Minister for Mileage - £4.40 Health and Social Services £0.90 Parking - £3.50 08/10/15 Cathedral Road Meeting with NHS Chairs / Mileage - £6.70 / Cardiff City To speak at CCAPSC £2.70 Stadium Parking - £4.00 13/10/15 All Nations To speak at Welsh Mileage - £10.70 Centre, Cardiff Occupational Therapy £2.70 Conference Parking - £8.00 14/10/15 Newport Road Meeting with Board of Linc Mileage - £2.25 Cymru Wales £2.25 20/10/15 Cardiff Bay Meeting with First Minister Mileage - £8.90 and Minister for Health and £0.90 Social Services. Parking - £8.00 22/10/15 Cardiff Bay Meeting with Finance Mileage - £3.90 Minister and Minister for £0.90 Health and Social Services. Parking - £3.00 03/11/15 Cardiff Bay / Meeting with First Minister Mileage - £9.80 SWALEC and Minister for Health and £1.80 Social Services / Speak at Parking - Public Health Wales £8.00 Conference 05/11/15 - Swansea Public Service Summit Mileage - £5.40 06/11/15 £5.40 09/11/15 Sophia Gardens Visit NWIS / Pre-meeting Mileage - £4.25 / Cardiff Bay with Minister for Health and £2.25 Social Services Parking - £2.00 10/11/15 Cardiff Bay / Meeting with First Minister Mileage - £10.90 Cathays Park and Minister for Health and £0.90 Social Services and Parking - Permanent Secretary.
    [Show full text]
  • Major Trauma & Vascular Hybrid Theatres, University Hospital of Wales
    Major Trauma & Vascular Hybrid Theatres, University Hospital of Wales Transport Statement Cardiff & Vale University Health Board June 2020 Notice This document and its contents have been prepared and are intended solely as information for Cardiff & Vale University Health Board and use in relation to Major Trauma & Vascular Hybrid Theatres at University Hospital of Wales. Atkins Limited assumes no responsibility to any other party in respect of or arising out of or in connection with this document and/or its contents. This document has 46 pages including the cover. Document history Document title: Transport Statement Document reference: Draft for Issue Revision Purpose description Originated Checked Reviewed Authorised Date Rev 1.0 Draft for Issue BH GM BH GM June 2020 Client signoff Client Cardiff & Vale University Health Board Project Major Trauma & Vascular Hybrid Theatres, University Hospital of Wales Job number 5187638 Draft for Issue | 1.0 | June 2020 Atkins | MTVH TS_Draft for Issue Page 2 of 46 Contents Chapter Page Major Trauma & Vascular Hybrid Theatres, University Hospital of Wales 5 1. Introduction 6 1.1. Overview 6 1.2. Project Background 6 1.3. TS Context 7 1.4. Report Structure 7 2. Planning Policy Context 8 2.1. Introduction 8 2.2. National Policy 8 2.3. Regional Policy 16 2.4. Local Policy 16 2.5. Policy Summary 18 3. Existing Transport Evaluation 19 3.1. Introduction 19 3.2. Existing Site 19 3.3. Proposed Development Location 24 3.4. Local Highway Network 27 3.5. Active Travel 29 3.6. Public Transport Provision 31 3.7. Personal Injury Collision Review 32 4.
    [Show full text]
  • WHY CARDIFF? CARDIFF Alumni and Friends Share What Cardiff Means to Them…
    FOR ALUMNI AND FRIENDS AUTUMN 2017 MyWHY CARDIFF? CARDIFF Alumni and friends share what Cardiff means to them… MY CARDIFF… is at the MY CARDIFF… is rowing MY CARDIFF… is doing aerobatics podium in St David’s down the Taff to Florida at 600 mph, 300 feet up in Hall | Page 10 – and beyond | Page 13 the air | Page 22 STAY IN TOUCH For general enquiries or queries about Cardiff Connect, please contact us via: T. +44 (0)29 2087 6473 E. [email protected] W. cardiff.ac.uk/alumni Deri House, 2-4 Park Grove, Cardiff, CF10 3BN /CardiffUniAlumni @CardiffAlumni bit.ly/cardiffalumni @cardiffuniversityalumni #BeTheDIFFerence Unless otherwise indicated, copyright of this publication belongs to Cardiff University. This document can be made available in alternative formats upon request. Thousands of Cardiff graduates have told us that they want to #BeTheDIFFerence Cardiff Connect Autumn 2017 How? By inspiring prospective students, Come home to Cardiff. In person or Editor – Shayoni Lynn (MA 2010) Assitant Editor – Alex Norton (BA 2015) providing internships and work online, in the classroom or at work; your Managing Editors – TJ Rawlinson, Claire Sanders placements, and taking part in Cardiff experience and expertise are invaluable Contributors – Chris Jones (BScEcon 1999), events across Wales and the world. to current and future Cardiff students. Caragh Medlicott (BA 2016, Creative Writing 2016-) Our new Alumni Volunteering Copy Editor – Nick Rawlinson To get involved, visit bit.ly/cu-getinvolved Design – Elevator Design in collaboration with Programme is designed to enable (this is a secure link) Barry Diamond Cardiff alumni like you to do just that.
    [Show full text]
  • Applications Decided by Delegated Powers Between 01/02/2016 and 29/02/2016
    Applications decided by Delegated Powers between 01/02/2016 and 29/02/2016 Total Count of Applications: 160 ADAM Application Registered Applicant Name Proposal Location Days taken 8 Week Decision Decision Date Number to decision target Achieved? 14/00505/DCI 21/02/2014 ADI Design DISCHARGE OF CONDITIONS 2 (BAT ST JAMES' CHURCH, 714 False Partial 05/02/2016 SURVEY), 4 (PROGRAMME OF NEWPORT ROAD, Discharge BUILDING RECORDING AND ADAMSDOWN of Condition ANALYSIS), 5 (DRAINAGE), 7 (s) (ALTERNATIVE CAR PARKING AREA), 8 (ROOF LIGHTS), 10 (LANDSCAPING SCHEME) AND 15 (ROAD TRAFFIC NOISE) OF PLANNING APPLICATION 08/01608/C Application Registered Applicant Name Proposal Location Days taken 8 Week Decision Decision Date Number to decision target Achieved? 15/03046/MJR 23/12/2015 Fusion Cardiff DISCHARGE OF CONDITIONS 14 UNIVERSITY OF WALES 49 True Full 10/02/2016 Metropolitan Ltd (DRAINAGE), 20 (CYCLE PARKING), INSTITUTE CARDIFF Discharge 21 (CONSTRUCTION MANAGEMENT HOWARD GARDENS of Condition PLAN) AND 22 (TRAVEL PLAN) OF CAMPUS, HOWARD PLANNING APPLICATION GARDENS, ADAMSDOWN, 14/02670/MJR CARDIFF, CF24 0SP 16/00316/MJR 11/02/2016 Lovell Partnerships Ltd DISCHARGE OF CONDITION 21 BRONTE HOTEL 158-164 12 True Full 23/02/2016 (CODE FOR SUSTAINABLE HOMES NEWPORT ROAD Discharge FINAL CERTIFICATES) OF PLANNING CARDIFF CF24 1DL of Condition APPLICATION 10/02302/DCI Application Registered Applicant Name Proposal Location Days taken 8 Week Decision Decision Date Number to decision target Achieved? 16/00026/MNR 07/01/2016 Ethical Property ADDING A RAMP ON
    [Show full text]
  • Cardiff Meetings & Conferences Guide
    CARDIFF MEETINGS & CONFERENCES GUIDE www.meetincardiff.com WELCOME TO CARDIFF CONTENTS AN ATTRACTIVE CITY, A GREAT VENUE 02 Welcome to Cardiff That’s Cardiff – a city on the move We’ll help you find the right venue and 04 Essential Cardiff and rapidly becoming one of the UK’s we’ll take the hassle out of booking 08 Cardiff - a Top Convention City top destinations for conventions, hotels – all free of charge. All you need Meet in Cardiff conferences, business meetings. The to do is call or email us and one of our 11 city’s success has been recognised by conference organisers will get things 14 Make Your Event Different the British Meetings and Events Industry moving for you. Meanwhile, this guide 16 The Cardiff Collection survey, which shows that Cardiff is will give you a flavour of what’s on offer now the seventh most popular UK in Cardiff, the capital of Wales. 18 Cardiff’s Capital Appeal conference destination. 20 Small, Regular or Large 22 Why Choose Cardiff? 31 Incentives Galore 32 #MCCR 38 Programme Ideas 40 Tourist Information Centre 41 Ideas & Suggestions 43 Cardiff’s A to Z & Cardiff’s Top 10 CF10 T H E S L E A CARDIFF S I S T E N 2018 N E T S 2019 I A S DD E L CAERDY S CARDIFF CAERDYDD | meetincardiff.com | #MeetinCardiff E 4 H ROAD T 4UW RAIL ESSENTIAL INFORMATION AIR CARDIFF – THE CAPITAL OF WALES Aberdeen Location: Currency: E N T S S I E A South East Wales British Pound Sterling L WELCOME! A90 E S CROESO! Population: Phone Code: H 18 348,500 Country code 44, T CR M90 Area code: 029 20 EDINBURGH DF D GLASGOW M8 C D Language: Time Zone: A Y A68 R D M74 A7 English and Welsh Greenwich Mean Time D R I E Newcastle F F • C A (GMT + 1 in summertime) CONTACT US A69 BELFAST Contact: Twinned with: Meet in Cardiff team M6 Nantes – France, Stuttgart – Germany, Xiamen – A1 China, Hordaland – Norway, Lugansk – Ukraine Address: Isle of Man M62 Meet in Cardiff M62 Distance from London: DUBLIN The Courtyard – CY6 LIVERPOOL Approximately 2 hours by road or train.
    [Show full text]
  • Jane Hutt: Businesses That Have Received Welsh Government Grants During 2011/12
    Jane Hutt: Businesses that have received Welsh Government grants during 2011/12 1 STOP FINANCIAL SERVICES 100 PERCENT EFFECTIVE TRAINING 1MTB1 1ST CHOICE TRANSPORT LTD 2 WOODS 30 MINUTE WORKOUT LTD 3D HAIR AND BEAUTY LTD 4A GREENHOUSE COM LTD 4MAT TRAINING 4WARD DEVELOPMENT LTD 5 STAR AUTOS 5C SERVICES LTD 75 POINT 3 LTD A AND R ELECTRICAL WALES LTD A JEFFERY BUILDING CONTRACTOR A & B AIR SYSTEMS LTD A & N MEDIA FINANCE SERVICES LTD A A ELECTRICAL A A INTERNATIONAL LTD A AND E G JONES A AND E THERAPY A AND G SERVICES A AND P VEHICLE SERVICES A AND S MOTOR REPAIRS A AND T JONES A B CARDINAL PACKAGING LTD A BRADLEY & SONS A CUSHLEY HEATING SERVICES A CUT ABOVE A FOULKES & PARTNERS A GIDDINGS A H PLANT HIRE LTD A HARRIES BUILDING SERVICES LTD A HIER PLUMBING AND HEATING A I SUMNER A J ACCESS PLATFORMS LTD A J RENTALS LIMITED A J WALTERS AVIATION LTD A M EVANS A M GWYNNE A MCLAY AND COMPANY LIMITED A P HUGHES LANDSCAPING A P PATEL A PARRY CONSTRUCTION CO LTD A PLUS TRAINING & BUSINES SERVICES A R ELECTRICAL TRAINING CENTRE A R GIBSON PAINTING AND DEC SERVS A R T RHYMNEY LTD A S DISTRIBUTION SERVICES LTD A THOMAS A W JONES BUILDING CONTRACTORS A W RENEWABLES LTD A WILLIAMS A1 CARE SERVICES A1 CEILINGS A1 SAFE & SECURE A19 SKILLS A40 GARAGE A4E LTD AA & MG WOZENCRAFT AAA TRAINING CO LTD AABSOLUTELY LUSH HAIR STUDIO AB INTERNET LTD ABB LTD ABER GLAZIERS LTD ABERAVON ICC ABERDARE FORD ABERGAVENNY FINE FOODS LTD ABINGDON FLOORING LTD ABLE LIFTING GEAR SWANSEA LTD ABLE OFFICE FURNITURE LTD ABLEWORLD UK LTD ABM CATERING FOR LEISURE LTD ABOUT TRAINING
    [Show full text]
  • IQE Strategy Update
    IQE Strategy update Leading innovation from within Tech hardware & equipment 14 January 2020 The breadth of IQE’s technology portfolio and ability to serve compound semiconductor chip customers in the US and Asia puts it in a good Price 50.0p position to benefit from rising demand for compound semiconductor Market cap £398m applications for 5G and connected devices. The share price has been hit by the shift to Asian-centric supply chains caused by US-Chinese trade Net debt (£m) at 30 June 2019 0.8 tensions, and resultant reductions to management guidance. Although the Shares in issue 796.1m timing of a recovery is difficult to gauge, we see scope for earnings recovery as IQE secures additional contracts in Asia and leverages its IP Free float 86.6% portfolio into sustainable profit growth and cash generation. Code IQE Primary exchange AIM Revenue PBT* EPS* DPS P/E Yield Secondary exchange N/A Year end (£m) (£m) (p) (p) (x) (%) 12/17 154.5 24.5 3.38 0.0 14.8 N/A Share price performance 12/18 156.3 14.0 1.38 0.0 36.2 N/A 12/19e 139.4 (8.0) (0.82) 0.0 N/A N/A 12/20e 152.1 3.0 0.28 0.0 178.6 N/A Note: *PBT and EPS are normalised, excluding amortisation of acquired intangibles, exceptional items and share-based payments. Global platform gives access to Asian supply chains The interconnected nature of semiconductor supply chains means it has taken time for IQE’s customers to feel the full impact of the US Department of Commerce’s decision in May to add Huawei to the Entity List.
    [Show full text]
  • IQE Plc and Cardiff University
    Innovation IQE plc International collaboration delivers positive results Wafers being ‘handled’ in IQE’s clean-room during post-production testing IQE, headquartered in Cardiff, is a global business that manufactures and supplies wafer products to the semiconductor The Business industry. Its products enable a range of high-tech applications, Key Achievements: including wireless and optical communications (smart phones, and • Developed enhanced the internet), photonic sensors and photovoltaics (solar panels). manufacturing and IQE successfully applied for an enhanced Knowledge Transfer testing procedures Partnership (KTP) to develop in-house expertise and processes that • Improved would test and improve the quality of one of their products. The communications with experience was extremely positive and helped to identify clients improvements in some key manufacturing processes. • Expanded existing JV The KTP Scheme is led by Innovate UK and funded by 13 with Cardiff University government organisations, including the Welsh Government. It enables businesses to innovate and grow by linking them with a university and a graduate to work on a specific project for up to 36 months. The “enhanced” KTP is unique to Wales and includes an international element; helping Welsh businesses become more competitive by identifying and exploiting unique knowledge and technology from overseas. This enhanced KTP delivered long-term Innovation IQE plc benefits, not only for the company but also for German graduate physicist, Alex Pooth, and Bristol University. Three years later, all The Academic Partner three are still reaping the benefits of the collaboration. Key Achievements: • Developed new The Business industry and research IQE was keen to access state-of-the-art analysis of its ‘gallium links nitride’ material, which is used in power control applications.
    [Show full text]
  • Overview of 2017 Annual Report and Financial Statements
    Overview of 2017 Annual report and financial statements | 2017 1 IQE PLC | Report and Annual Accounts 2017 Company No: 3745726 Overview of 2017 05: Chairman’s report to shareholders 08: Business review 13: Outlook Strategic report 15: Strategic report 18: Our business 21: CSR, health, safety & environment 28: Principal risks & uncertainties 38: Financial review Directors’ report 41: Compliance & governance statements 52: Director’s report 55: Remuneration statements 64: Annual report on remuneration 74: Officers & professional advisors Financial statements 80: Financial statements 91: Notes to the financial statements It is with the deepest sadness that the Board of announced in April 2018 that its long-serving Chief Financial Officer, Phillip J Rasmussen BSc ACA, had died. His death follows a cycling incident that took place on 1 April 2018 whilst on holiday abroad. On behalf of the Board and all of Mr Rasmussen’s IQE colleagues, IQE President and Chief Executive Officer, Drew Nelson, commented: “The news of Phil’s death has shocked and distressed all of us at IQE. The tragedy, of course, will be most deeply felt by Phil’s family, who we send our heartfelt condolences to at this terrible time. It is also a tragedy for so many of us who considered Phil a friend as much as a colleague. Phil was a great colleague and an accomplished CFO. He made the role his own, contributing so much over his ten years with us to IQE’s current strength; to the detailed and principled way we do things; to the potential we see before us as a firm.
    [Show full text]
  • CITY of NEWPORT Investment Prospectus
    CITY OF NEWPORT Investment Prospectus Dinas CASNEWYDD OUR OBJECTIVES Foreword On behalf of the Newport Economic Network we are delighted to • Deliver shared prosperity present the first investment prospectus for the city of Newport. The prospectus has been prepared by partners across the city and sets out • Build an economic environment our ambitions to transform Newport over the next 10 years. Much has of growth and success been achieved in recent years – the completion and opening of Friars Walk retail and leisure centre in 2015 has perhaps been the best example of the • Move Newport up the city’s transformation. ‘value chain’ Newport’s location, sense of identity and growing confidence means the foundations are now in place to fulfil the city’s economic potential. The city has a proud and varied history and we want to build a future which respects this legacy whilst recognising that future economic growth will be founded on very different skills. We are home to many successful and growing businesses and the city is projected to grow significantly over the next 10 years. Our key aim over that period is to create the conditions which will stimulate further investment. This means we need to build our social capital as well as maintaining our focus on physical regeneration. Ultimately we want to make Newport a city where everyone can achieve their potential. The abolition of the Severn Bridge tolls have removed a critical barrier to investment and we now stand on the verge of an important new era for the city. Newport will soon be home to the Wales International Convention Centre which is another example of how the profile of the city is changing.
    [Show full text]
  • GROWTH and CHARACTERISATION of LARGE DIAMETER Gasb SUBSTRATES
    GROWTH AND CHARACTERISATION OF LARGE DIAMETER GaSb SUBSTRATES Mark J. Furlong*a, Lisa P. Allenb, Patrick J. Flintb, Rebecca J. Martineza, S. Amirhaghia, G. Meshewb, G. Dallasb, A. Mowbraya and B. Smitha aWafer Technology Ltd. (IQE Plc), 34 Maryland Road, Tongwell, Milton Keynes, England, U.K., MK15 8HJ; bGalaxy Compound Semiconductors Inc. (IQE Plc), 9922 East Montgomery Avenue, #7, Spokane, WA 99206, USA BIOGRAPHY Dr. Mark J. Furlong is the General Manager of IQE Group substrate divisions, Wafer Technology Ltd. and Galaxy Compound Semiconductors Inc. Prior to joining Wafer Technology in early 2003, he held the position of Technical Sales Manager at IQE (Europe) Ltd. and was responsible for MOCVD and MBE epitaxial wafer sales across the Far East. Over 1997-1999, he was based at Epitaxial Products International Ltd. where he assumed various technical management roles. Prior to this Furlong was in Paris and worked for the CNRS on the development of novel Group II-VI/III-V based photovoltaic cells. He was awarded an Industrial Fellowship from the Royal Society (London, U.K.) to pursue this work. He holds a Ph.D. degree in semiconductor science and technology from the University of Bath (1996) and a B.Sc. (Hons.) degree in Chemistry from the University of London (1992). He also holds a Diploma in Management (Dist.) from the Open University, U.K (2002). TECHNICAL ABSTRACT Gallium antimonide (GaSb) is an important Group III-V compound semiconductor for photodetectors that operate in the mid (3-5 μm) to the long wavelength region (8-12 μm) of the infrared (IR) spectrum.
    [Show full text]
  • IQE Announces Successful Development of New 5G Filter Product Built on Creo™
    IQE Announces Successful Development of New 5G Filter Product Built on cREO™ 12 November 2020 Silex Systems Limited (Silex) (ASX: SLX) (OTCQX: SILXY) provides the following information disclosed by IQE in London (AIM: IQE), relating to wholly owned subsidiary Translucent Inc’s cREO™ technology agreement with IQE. IQE has announced the successful development of a new high frequency (RF) filter product (called IQepiMo™) which is built on the cREO™ technology platform purchased from Translucent in 2018. IQE states this new product can eliminate technical issues related to the demands that 5G technology places on electronic components, including RF filters, which are key to managing high frequency signals in 5G devices such as mobile handsets. Trials of IQE’s new RF filter product are underway with potential customers and partners. The full IQE announcement is attached hereto. Under the 2015 Agreement, Translucent Inc. will be eligible for minimum annual royalties for the cREO™ technology and a perpetual royalty of at least 3% will be payable to Translucent on the sale of any IQE products that utilise the cREO™ technology. The first minimum royalty payment of US$400,000 for the year ended CY2019 was received in March 2020. Authorised for release by the Silex Board of Directors. Further information on the Company’s activities can be found on the Silex website: www.silex.com.au or by contacting: Michael Goldsworthy Julie Ducie CEO/Managing Director CFO/Company Secretary T +61 2 9704 8888 T +61 2 9704 8888 E [email protected] E
    [Show full text]